Broad Institute of MIT and Harvard
Dr. Le Cong obtained his B.S. with highest honor from Tsinghua University, his Ph.D. from Harvard University co-advised by Drs. Feng Zhang and George Church, and is currently a Postdoctoral Associate at Broad Institute of MIT and Harvard in Dr. Aviv Regev’s laboratory. He completed his thesis work mainly in Dr. Zhang’s lab, where he did pioneering studies on genetic and epigenetic engineering, focusing on developing technologies based on TALE and CRISPR-Cas systems and adapting related technology for potential gene therapy applications. Dr. Cong has published works in journals including Science, Nature, Cell, Nature Biotechnology, and Nature Methods, and written for Springer’s Book Series Neuromethods and Methods in Molecular Biology. He is also inventor on 20+ related patent applications, with nine patents on CRISPR and TALE technology granted.